Attacking a nexus of the oncogenic circuitry by reversing aberrant eIF4F-mediated translation

Peter B Bitterman1, Vitaly A Polunovsky

  • 1Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA.

Insights

Cancer cells hijack key signaling hubs like the translation-initiation complex eIF4F to promote malignancy. Targeting these critical nodes offers a promising therapeutic strategy for next-generation cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Signaling Networks

Background:

  • Cancers, despite genetic diversity, share common perturbed pathways converging on regulatory nodes.
  • These nodes link intracellular signaling with cellular metabolism, presenting therapeutic targets.
  • The translation-initiation complex eIF4F is a critical hub integrating cancer-related pathways.

Purpose of the Study:

  • To highlight the role of the eIF4F complex as a central integrator of oncogenic signaling.
  • To underscore the potential of targeting eIF4F for cancer therapy.
  • To identify the need for genome-wide methods to assess responses to eIF4F inhibitors.

Main Methods:

  • The study reviews the role of eIF4F in integrating cancer signaling pathways.
  • It discusses the implications of eIF4F hyperactivation in cancer development.
  • The need for systems-level evaluation of therapeutic responses is emphasized.

Main Results:

  • Hyperactivation of eIF4F by oncogenic signals drives a translational shift towards malignancy.
  • The eIF4F complex acts as a central hub, amplifying oncogenic signals.
  • Small-molecule inhibitors targeting eIF4F are under development.

Conclusions:

  • Targeting critical network hubs like eIF4F is a key strategy for next-generation cancer therapeutics.
  • Understanding eIF4F's role provides insights into cancer cell reprogramming.
  • Developing objective, genome-wide methods to evaluate drug response is crucial.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...